Evidence of widespread binding of HLA class I molecules to peptides.

Evidence of widespread binding of HLA class I molecules to peptides.

We have tested the binding of HLA class I proteins to peptides using a solid-phase binding assay. We tested 102 peptides, mostly derived from the HIV gag and HIV pol sequences. Most peptides did not bind to any class I protein tested. The pattern of binding among the three class I proteins tested, H...

Full description

Bibliographic Details
Main Authors:	Frelinger, J, Gotch, F, Zweerink, H, Wain, E, Mcmichael, A
Format:	Journal article
Language:	English
Published:	1990

Similar Items

Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLA-A*0201. Effect on maturation and peptide presentation.
by: Warburton, R, et al.
Published: (1994)

Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLA-A*0201. Effect on maturation and peptide presentation.
by: Warburton, R, et al.
Published: (1994)

Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
by: Tussey, L, et al.
Published: (1994)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
by: Matsui, M, et al.
Published: (1994)

Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
by: Bodmer, H, et al.
Published: (1989)

IMMUNOGENIC HIV VARIANT PEPTIDES THAT BIND TO HLA-B8 BUT FAIL TO STIMULATE CYTOTOXIC T-LYMPHOCYTE RESPONSES
by: Mcadam, S, et al.
Published: (1995)

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
by: Braud, V, et al.
Published: (1997)

TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
by: Braud, V, et al.
Published: (1998)

Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E.
by: O'Callaghan, C, et al.
Published: (1998)

An HLA class I specific monoclonal antibody that fails to bind to all HLA-A antigens.
by: Ellis, SA, et al.
Published: (1985)

Biophysical evidence for conformational change in MHC class I molecules upon peptide binding
by: Springer, S, et al.
Published: (1997)

Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules.
by: Tafuro, S, et al.
Published: (2001)

Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E.
by: Bland, F, et al.
Published: (2003)

Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay
by: Walters, LC, et al.
Published: (2020)

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.
by: Berke, Z, et al.
Published: (2000)

Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
by: Mcmichael, A, et al.
Published: (1988)

B-POCKET TRANSPLANT FROM HLA-A2 INTO B27 CHANGES REQUIREMENT FOR P-2 ANCHOR RESIDUE IN PEPTIDE PRESENTATION
by: Colbert, R, et al.
Published: (1993)

A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
by: Moots, R, et al.
Published: (1991)

Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53.
by: Smith, K, et al.
Published: (1996)

INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE
by: Moots, R, et al.
Published: (1993)

INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE
by: Moots, R, et al.
Published: (1993)

HLA restriction of cell-mediated lysis of influenza virus-infected human cells.
by: Mcmichael, A, et al.
Published: (1977)

HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
by: Barouch, D, et al.
Published: (1995)

Identification of novel HIV-1-derived HLA-E-binding peptides
by: Hannoun, Z, et al.
Published: (2018)

DIFFERENCES IN PEPTIDE PRESENTATION BETWEEN B27 SUBTYPES - THE IMPORTANCE OF THE P1 SIDE-CHAIN IN MAINTAINING HIGH-AFFINITY PEPTIDE BINDING TO B-ASTERISK-2703
by: Colbert, R, et al.
Published: (1994)

Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes.
by: Toshitani, K, et al.
Published: (1996)

The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules.
by: Cerundolo, V, et al.
Published: (1991)

Definition of peptide binding motifs amongst the HLA-A*30 allelic group.
by: Krausa, P, et al.
Published: (2000)

Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule.
by: Ellis, SA, et al.
Published: (1990)

HLA-peptide tetrameric complexes.
by: Ogg, G, et al.
Published: (1998)

Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703.
by: Colbert, R, et al.
Published: (1994)

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
by: Colbert, R, et al.
Published: (1993)

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
by: Colbert, R, et al.
Published: (1993)

Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.
by: Koch, M, et al.
Published: (2007)

HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides.
by: Davenport, M, et al.
Published: (1997)

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.
by: Braud, V, et al.
Published: (1999)

Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses.
by: McAdam, S, et al.
Published: (1995)

The arrival of HLA class II tetramers.
by: Mcmichael, A, et al.
Published: (1999)

HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2.
by: Hill, AB, et al.
Published: (1994)

HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes.
by: Mcmichael, A, et al.
Published: (1986)